Abstract
Objective: To determine the frequency of measles vaccination among children under 5 years of age presenting with measles and to compare the outcomes between vaccinated and unvaccinated children. Outcomes were defined as (i) prolonged hospital admission of two days or more (primary outcome, taken as the marker of severe disease) and (ii) measles-related complications (secondary outcome).
Methods: This descriptive cross-sectional study was conducted at the Department of Paediatrics, Benazir Bhutto Hospital, Rawalpindi, from October 2025 to December 2025, and reported in accordance with the STROBE guidelines for cross-sectional studies. A total of 150 children aged 1–5 years of either sex were enrolled using non-probability consecutive sampling. Measles was defined by the WHO clinical case definition (fever ≥38 °C with a generalised maculopapular rash lasting ≥3 days, together with at least one of cough, coryza, or conjunctivitis). A child was classified as vaccinated when at least one dose of a measles-containing vaccine given at or after 9 months of age was documented on the Expanded Program on Immunisation (EPI) card, and as unvaccinated when no dose was documented. Children with chickenpox, other skin infections, congenital anomalies, chronic illnesses, immunocompromised status, or incomplete vaccination records were excluded. Groups were compared using the chi-square test, and effect sizes were reported as odds ratios (OR), risk ratios (RR), and absolute risk differences with 95% confidence intervals (CI).
Results: The mean age of the children was 3.18 ± 1.21 years, and the mean weight was 12.46 ± 2.84 kg. Of the 150 children, 38 (25.3%) were vaccinated, and 112 (74.7%) were unvaccinated. Prolonged hospital admission was required by 57 of 112 (50.9%) unvaccinated children compared with 10 of 38 (26.3%) vaccinated children (OR 2.90, 95% CI 1.29–6.53; RR 1.93, 95% CI 1.10–3.39; absolute risk difference 24.6%, 95% CI 7.8–41.4; p = 0.009). Complications were observed in 73 (48.7%) children overall, with pneumonia being the most common complication in 34 (22.7%), followed by diarrhoea in 21 (14.0%), otitis media in 10 (6.7%), and encephalitis in 8 (5.3%). The overall frequency of complications did not differ significantly between unvaccinated (55/112, 49.1%) and vaccinated (18/38, 47.4%) children (OR 1.07, 95% CI 0.51–2.24; p = 0.853).
Conclusion: Unvaccinated children < 5 years of age with measles had a significantly greater need for prolonged hospital admission than vaccinated children, indicating that measles vaccination attenuates the severity of illness in children who acquire the infection. The overall frequency of complications did not differ significantly between the two groups; this null result should be interpreted cautiously, given the small number of vaccinated children and the correspondingly wide confidence interval. These findings support the need to strengthen routine measles immunisation coverage in children under 5 years of age.
Keywords: Measles; Measles Vaccine; Vaccination; Child, Preschool; Hospitalization; Treatment Outcome; Immunization Programs; Pakistan.
References
Do LAH, Mulholland K. Measles 2025. N Engl J Med. 2025;393(24):2447-58. https://doi.org/10.1056/NEJMra2504516
World Health Organization. Measles [Internet]. Geneva: World Health Organization; 2026 [updated 2026 Jul 15; cited 2026 Aug 9]. Available from: https://www.who.int/news-room/fact-sheets/detail/measles
Minta AA, Ferrari M, Antoni S, Portnoy A, Sbarra AN, Lambert B, et al. Progress toward measles elimination — worldwide, 2000-2023. MMWR Morb Mortal Wkly Rep. 2024;73(45):1036-42. https://doi.org/10.15585/mmwr.mm7345a4
Venkatesan P. Worrying global decline in measles immunization. Lancet Microbe. 2022;3(1): e9. https://doi.org/10.1016/S2666-5247(21)00335-9
Berche P. History of measles. Presse Med. 2022;51(3):104149. https://doi.org/10.1016/j.lpm.2022.104149
Turaiche M, Grigoras ML, Bratosin F, Bogdan I, Bota AV, Cerbu B, et al. Disease progression, clinical features, and risk factors for pneumonia in unvaccinated children and adolescents with measles: a re-emerging disease in Romania. Int J Environ Res Public Health. 2022;19(20):13165. https://doi.org/10.3390/ijerph192013165
Stein-Zamir C, Shoob H, Abramson D. Measles clinical presentation, hospitalization and vaccination status among children in a community-wide outbreak. Vaccine. 2023;41(17):2764-8. https://doi.org/10.1016/j.vaccine.2023.03.043
Leung J, Munir NA, Mathis AD, Filardo TD, Rota PA, Sugerman DE, et al. The effects of vaccination status and age on clinical characteristics and severity of measles cases in the United States in the postelimination era, 2001-2022. Clin Infect Dis. 2025;80(3):663-72. https://doi.org/10.1093/cid/ciae470
Khalil U, Masood T, Illiyas T. Comparison of frequency of measles complications among vaccinated and non-vaccinated children presenting at tertiary care hospital. Biol Clin Sci Res J. 2025;6(12):59-63. https://doi.org/10.54112/bcsrj.v6i12.2194
Ashraf J, Taj F, Sadia A, Shafi-u-Zaman, Afzal U, Ijaz M, et al. Frequency of measles vaccination and its complications among children: a single centred study. J Liaquat Natl Hosp. 2025;3(1):29-35. https://doi.org/10.37184/jlnh.2959-1805.2.33
Endalamaw D, Nibret E, Munshea A, Mekonnen F, Tadesse S, Zeru T, et al. Measles vaccine effectiveness in African children: a systematic review and meta-analysis. BMC Infect Dis. 2024;24(1):1330. https://doi.org/10.1186/s12879-024-10239-w
Munday JD, Atkins KE, Klinkenberg D, Meurs M, Fleur E, Hahné SJM, et al. Estimating the risk and spatial spread of measles in populations with high MMR uptake: using school-household networks to understand the 2013 to 2014 outbreak in the Netherlands. PLoS Med. 2024;21(10): e1004466. https://doi.org/10.1371/journal.pmed.1004466
Tariq S, Niaz F, Afzal Y, Tariq R, Nashwan AJ, Ullah I. Pakistan at the precipice: the looming threat of measles amidst the COVID-19 pandemic. Front Public Health. 2022; 10:1000906. https://doi.org/10.3389/fpubh.2022.1000906
Comfort H, Lafta RK, Flaxman AD, Hagopian A, Duber HC. Association between subnational vaccine coverage, migration, and incident cases of measles, mumps, and rubella in Iraq, 2001-2016. Front Public Health. 2021; 9:689458. https://doi.org/10.3389/fpubh.2021.689458
Alhaddad AR, Ahmadnezhad E, Fotouhi A. The vaccination coverage rate in under-5 children in Nasiriyah, Iraq before and during the COVID-19 pandemic. Epidemiol Health. 2022;44: e2022035. https://doi.org/10.4178/epih.e2022035
Mathis AD, Raines K, Filardo TD, Wiley N, Leung J, Rota PA, et al. Measles update — United States, January 1-April 17, 2025. MMWR Morb Mortal Wkly Rep. 2025;74(14):232-8. https://doi.org/10.15585/mmwr.mm7414a1
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10): e296. https://doi.org/10.1371/journal.pmed.0040296.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2026 Amber Khalid, Muhammad Asim, Sana Abid, Aden Khalid Shah, Muhammad Usman Ali, Hajra Afzal

